Annual FCF
-$182.94 M
-$19.54 M-11.96%
December 31, 2024
Summary
- As of March 8, 2025, NMRA annual free cash flow is -$182.94 million, with the most recent change of -$19.54 million (-11.96%) on December 31, 2024.
- During the last 3 years, NMRA annual FCF has fallen by -$106.70 million (-139.96%).
- NMRA annual FCF is now -551.95% below its all-time high of -$28.06 million, reached on December 1, 2020.
Performance
NMRA Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$50.34 M
-$16.86 M-50.34%
December 31, 2024
Summary
- As of March 8, 2025, NMRA quarterly free cash flow is -$50.34 million, with the most recent change of -$16.86 million (-50.34%) on December 31, 2024.
- Over the past year, NMRA quarterly FCF has dropped by -$16.86 million (-50.34%).
- NMRA quarterly FCF is now -267.28% below its all-time high of -$13.71 million, reached on June 1, 2021.
Performance
NMRA Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$182.94 M
+$1.15 M+0.62%
December 31, 2024
Summary
- As of March 8, 2025, NMRA TTM free cash flow is -$182.94 million, with the most recent change of +$1.15 million (+0.62%) on December 31, 2024.
- Over the past year, NMRA TTM FCF has increased by +$1.15 million (+0.62%).
- NMRA TTM FCF is now -1078.94% below its all-time high of -$15.52 million, reached on March 1, 2021.
Performance
NMRA TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
NMRA Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -12.0% | -50.3% | +0.6% |
| 3 y3 years | -140.0% | -88.1% | -72.4% |
| 5 y5 years | - | -88.1% | -72.4% |
NMRA Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -140.0% | at low | -94.4% | +10.4% | -96.5% | +7.8% |
| 5 y | 5-year | -552.0% | at low | -267.3% | +10.4% | -1078.9% | +7.8% |
| alltime | all time | -552.0% | at low | -267.3% | +10.4% | -1078.9% | +7.8% |
Neumora Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$182.94 M(+12.0%) | -$50.34 M(+50.3%) | -$182.94 M(-0.6%) |
| Sep 2024 | - | -$33.48 M(-40.4%) | -$184.08 M(-7.2%) |
| Jun 2024 | - | -$56.16 M(+30.7%) | -$198.41 M(+14.5%) |
| Mar 2024 | - | -$42.95 M(-16.6%) | -$173.27 M(+6.0%) |
| Dec 2023 | -$163.40 M(+41.6%) | -$51.49 M(+7.7%) | -$163.40 M(+14.8%) |
| Sep 2023 | - | -$47.81 M(+54.1%) | -$142.30 M(+18.2%) |
| Jun 2023 | - | -$31.02 M(-6.2%) | -$120.38 M(+3.7%) |
| Mar 2023 | - | -$33.08 M(+8.8%) | -$116.12 M(+0.6%) |
| Dec 2022 | -$115.41 M | -$30.39 M(+17.4%) | -$115.41 M(+0.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$25.89 M(-3.2%) | -$114.56 M(+7.9%) |
| Jun 2022 | - | -$26.76 M(-17.3%) | -$106.14 M(+14.0%) |
| Mar 2022 | - | -$32.36 M(+9.6%) | -$93.08 M(+22.1%) |
| Dec 2021 | -$76.24 M(+171.7%) | - | - |
| Dec 2021 | - | -$29.54 M(+69.1%) | -$76.24 M(+63.3%) |
| Sep 2021 | - | -$17.47 M(+27.5%) | -$46.70 M(+59.8%) |
| Jun 2021 | - | -$13.71 M(-11.7%) | -$29.22 M(+88.3%) |
| Mar 2021 | - | -$15.52 M | -$15.52 M |
| Dec 2020 | -$28.06 M | - | - |
FAQ
- What is Neumora Therapeutics annual free cash flow?
- What is the all time high annual FCF for Neumora Therapeutics?
- What is Neumora Therapeutics annual FCF year-on-year change?
- What is Neumora Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Neumora Therapeutics?
- What is Neumora Therapeutics quarterly FCF year-on-year change?
- What is Neumora Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Neumora Therapeutics?
- What is Neumora Therapeutics TTM FCF year-on-year change?
What is Neumora Therapeutics annual free cash flow?
The current annual FCF of NMRA is -$182.94 M
What is the all time high annual FCF for Neumora Therapeutics?
Neumora Therapeutics all-time high annual free cash flow is -$28.06 M
What is Neumora Therapeutics annual FCF year-on-year change?
Over the past year, NMRA annual free cash flow has changed by -$19.54 M (-11.96%)
What is Neumora Therapeutics quarterly free cash flow?
The current quarterly FCF of NMRA is -$50.34 M
What is the all time high quarterly FCF for Neumora Therapeutics?
Neumora Therapeutics all-time high quarterly free cash flow is -$13.71 M
What is Neumora Therapeutics quarterly FCF year-on-year change?
Over the past year, NMRA quarterly free cash flow has changed by -$16.86 M (-50.34%)
What is Neumora Therapeutics TTM free cash flow?
The current TTM FCF of NMRA is -$182.94 M
What is the all time high TTM FCF for Neumora Therapeutics?
Neumora Therapeutics all-time high TTM free cash flow is -$15.52 M
What is Neumora Therapeutics TTM FCF year-on-year change?
Over the past year, NMRA TTM free cash flow has changed by +$1.15 M (+0.62%)